INTRODUCTION: Despite recent advances in prevention and treatment, cytomegalovirus
(CMV) is still a major complication in transplant patients. This study sought to analyze the …

Background: Infection with cytomegalovirus (CMV) remains a potentially serious
complication in transplant patients. In this study we explored the risk factors for CMV …

Background Cytomegalovirus (CMV) disease typically occurs during the first year after solid
organ transplantation, after cessation of antiviral prophylaxis. CMV occurring after the first …

Introduction. Recurrence of cytomegalovirus (CMV) infection following solid organ
transplantation causes mortality and morbidity in allograft recipients. The aim of this study …

OBJECTIVE: Cytomegalovirus (CMV) is the most common viral infection after
allotransplantation; it can be a major cause of morbidity and mortality. Our aim was to …

Introduction The clinical course of cytomegalovirus (CMV) infections in the current era is
poorly described. We characterized the symptoms and outcome of all CMV infections in a …

OBJECTIVES: Cytomegalovirus (CMV) is a common opportunistic infection following renal
transplantation (RTx). It responds promptly to antiviral treatment. The mortality rate reaches …

BACKGROUND: Cytomegalovirus (CMV) is one of the most frequently encountered
opportunistic viral pathogens in renal transplantation. Approximately 60% of transplant …

CMV infection is a major cause of morbidity in patients receiving solid organ transplants.
CMV is widely distributed in the general population with seroprevalence ranging from 30 to …

Cytomegalovirus (CMV) disease typically occurs 1 to 4 months (median 35 days) after solid
organ transplantation. Recent reports documented that the natural history of CMV disease …